Clinical Trial

Using Routine Inflammatory and Metabolic Blood Tests (Bedside Included) to Predict Brain Injury in Children After Minor Head Trauma

Study acronym: paeds_mTBI_Bio

Not Yet Recruiting

Record status

This record was last updated March 31, 2026 (before its estimated June 20, 2026 completion). Its status may not reflect the trial's current state.

Summary

Traumatic brain injury (TBI) poses significant strains on the paediatric population, for which the possible side effects of diagnostic imagistics could induce life-altering conditions. Routine inflammatory and metabolic biomarkers (complete blood count, C reactive protein, glucose) are frequently sampled in the paediatric patients admited within emergency departments, including the low-resource settings. This study aims to retrospectively document whether such routine blood biomarkers could predict a positive head CT scan and subsequently contribute to a prediction score, ment to enable more accurate decision on which minor TBI paediatric patients should be submitted to diagnotic imagistics.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-30.

Trial Details

NCT Number	NCT07397091
Lead Sponsor	Iuliu Hatieganu University of Medicine and Pharmacy Collaborators: Children's Emergency Clinical Hospital Cluj-Napoca
Conditions	Brain Injury Traumatic Mild
Enrollment	800 participants
Start Date	2026-04-20
Primary Completion	2026-06-20 (estimated)
Study Completion	2026-06-20 (estimated)
Updated on ClinicalTrials.gov	2026-03-31